Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-18T20:39:01.639Z Has data issue: false hasContentIssue false
  • English
  • Français

A Tertiary Care Cancer Center Experience of the 2007 Outbreak of Serratia marcescens Bloodstream Infection Due to Prefilled Syringes

Published online by Cambridge University Press:  02 January 2015

Roy F. Chemaly ,
Dhanesh B. Rathod  and
Issam I. Raad
Roy F. Chemaly*
Affiliation:
University of TexasM. D. Anderson Cancer Center, Houston
Dhanesh B. Rathod
Affiliation:
University of TexasM. D. Anderson Cancer Center, Houston
Issam I. Raad
Affiliation:
University of TexasM. D. Anderson Cancer Center, Houston
*
Department of ID/IC/EH, University of Texas M. D. Anderson Cancer Center, 1515 Holcombc Blvd, Box 1460, Houston, TX 77030 (rfchemaly@mdanderson.org)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 12 , December 2009 , pp. 1237 - 1238
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

References

1.Su, JR, Blossom, DB, Chung, W, et al.Epidemiologic investigation of a 2007 outbreak of Serratia marcescens bloodstream infection in Texas caused by contamination of syringes prefilled with heparin and saline. Infect Control Hosp Epidemiol 2009;30:593–595.CrossRefGoogle ScholarPubMed
2.Chemaly, RF, Tarrand, J, Adachi, J, et al. Investigation of an outbreak of Serratia marcescens bacteremia in cancer patients leading to a national recall of a second unsuspected contaminated source: time for antimicrobial lock therapy? In: Program and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; October 2008; Washington, DC. Abstract K903.Google Scholar
3. AM2 PAT, Ine issues nationwide recall of prefilled heparin lock flush solution USP (5 mL in 12 mL syringes). Available at: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2007/ucml12333.htm. Accessed October 20, 2009.Google Scholar
4. B. Braun's supplier prompts voluntary recall of all lots and all sizes of prefilled heparin and normal saline flush syringes. Available at: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ucm112343.htm. Accessed October 20, 2009.Google Scholar